Nothing Special   »   [go: up one dir, main page]

EE03440B1 - Bioloogilise toimega bensotiasolooni etaanamiinid ja nende valmistamise protsess - Google Patents

Bioloogilise toimega bensotiasolooni etaanamiinid ja nende valmistamise protsess

Info

Publication number
EE03440B1
EE03440B1 EE9800193A EE9800193A EE03440B1 EE 03440 B1 EE03440 B1 EE 03440B1 EE 9800193 A EE9800193 A EE 9800193A EE 9800193 A EE9800193 A EE 9800193A EE 03440 B1 EE03440 B1 EE 03440B1
Authority
EE
Estonia
Prior art keywords
ethanamines
preparation
biologically active
benzothiazolone
active benzothiazolone
Prior art date
Application number
EE9800193A
Other languages
English (en)
Other versions
EE9800193A (et
Inventor
Victor Bonnert Roger
Charles Brown Roger
Alan Cage Peter
Cheshire David
Ince Francis
Original Assignee
Astra Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharmaceuticals Limited filed Critical Astra Pharmaceuticals Limited
Publication of EE9800193A publication Critical patent/EE9800193A/et
Publication of EE03440B1 publication Critical patent/EE03440B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EE9800193A 1995-12-23 1996-12-13 Bioloogilise toimega bensotiasolooni etaanamiinid ja nende valmistamise protsess EE03440B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526511.2A GB9526511D0 (en) 1995-12-23 1995-12-23 Pharmaceutically active compounds
PCT/SE1996/001650 WO1997023470A1 (en) 1995-12-23 1996-12-13 Biologically active benzothiazolone ethanamines

Publications (2)

Publication Number Publication Date
EE9800193A EE9800193A (et) 1998-12-15
EE03440B1 true EE03440B1 (et) 2001-06-15

Family

ID=10786064

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800193A EE03440B1 (et) 1995-12-23 1996-12-13 Bioloogilise toimega bensotiasolooni etaanamiinid ja nende valmistamise protsess

Country Status (27)

Country Link
US (1) US5929100A (et)
EP (1) EP0918760B1 (et)
JP (1) JP2000502681A (et)
KR (1) KR19990076688A (et)
CN (1) CN1072214C (et)
AR (1) AR005008A1 (et)
AT (1) ATE209638T1 (et)
AU (1) AU704506B2 (et)
BR (1) BR9612234A (et)
CA (1) CA2238877A1 (et)
CZ (1) CZ288704B6 (et)
DE (1) DE69617472D1 (et)
EE (1) EE03440B1 (et)
GB (1) GB9526511D0 (et)
HU (1) HUP9900100A3 (et)
IL (2) IL124998A0 (et)
IS (1) IS4759A (et)
MX (1) MX9804828A (et)
NO (1) NO982927D0 (et)
NZ (1) NZ325500A (et)
PL (1) PL327475A1 (et)
RU (1) RU2177476C2 (et)
SK (1) SK82098A3 (et)
TR (1) TR199801196T2 (et)
TW (1) TW401411B (et)
WO (1) WO1997023470A1 (et)
ZA (1) ZA9610354B (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009018A1 (fr) * 1997-08-14 1999-02-25 Kirin Beer Kabushiki Kaisha DERIVES DE BENZOTHIAZOLONE PRESENTANT UNE ACTIVITE SELECTIVE D'AGONISTE DU RECEPTEUR β2
PE20050130A1 (es) * 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos
GB0218629D0 (en) * 2002-08-09 2002-09-18 Novartis Ag Organic compounds
DE602004021959D1 (de) * 2003-11-21 2009-08-20 Theravance Inc Verbindungen mit agonistischer wirkung am beta2-adrenergen rezeptor und am muscarinischen rezeptor
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200738659A (en) * 2005-08-29 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
EP2303873A4 (en) 2008-06-18 2012-01-04 Astrazeneca Ab BENZOXAZINE DERIVATIVES AS A BETA2 ADRENORE RECEPTOR AGONIST FOR THE TREATMENT OF RESPIRATORY DISEASES

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
AU4945185A (en) * 1984-11-08 1986-05-15 Syntex (U.S.A.) Inc. Dialkyl aminoethylaniline derivatives
DE3728695A1 (de) * 1987-08-25 1989-03-09 Schering Ag Neue benzimidazol-derivate
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
US5648370A (en) * 1990-11-20 1997-07-15 Astra Pharmaceuticals Limited 7-(2-aminoethyl) benzothiazolones

Also Published As

Publication number Publication date
IL142502A0 (en) 2002-03-10
HUP9900100A3 (en) 2001-10-29
DE69617472D1 (de) 2002-01-10
CN1072214C (zh) 2001-10-03
CZ288704B6 (cs) 2001-08-15
PL327475A1 (en) 1998-12-07
ATE209638T1 (de) 2001-12-15
JP2000502681A (ja) 2000-03-07
HUP9900100A2 (hu) 1999-05-28
US5929100A (en) 1999-07-27
RU2177476C2 (ru) 2001-12-27
CA2238877A1 (en) 1997-07-03
KR19990076688A (ko) 1999-10-15
SK82098A3 (en) 1998-11-04
TW401411B (en) 2000-08-11
WO1997023470A1 (en) 1997-07-03
EP0918760A1 (en) 1999-06-02
AR005008A1 (es) 1999-04-07
IS4759A (is) 1998-05-27
NZ325500A (en) 1999-01-28
CZ168498A3 (cs) 1998-09-16
EP0918760B1 (en) 2001-11-28
NO982927L (no) 1998-06-23
EE9800193A (et) 1998-12-15
AU704506B2 (en) 1999-04-22
MX9804828A (es) 1998-09-30
CN1211242A (zh) 1999-03-17
BR9612234A (pt) 1999-07-13
AU1402597A (en) 1997-07-17
ZA9610354B (en) 1997-06-23
NO982927D0 (no) 1998-06-23
TR199801196T2 (xx) 1998-10-21
IL124998A0 (en) 1999-01-26
GB9526511D0 (en) 1996-02-28

Similar Documents

Publication Publication Date Title
BR9611198A (pt) Composto processo de preparação do mesmo e composição farmacêutica
FI973426A0 (fi) Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi
BR9606607A (pt) Composto método de aperfeiçoamento de transporte de uma droga ou outro ativo método de fabricação de um medicamento composto uso método de tratamento de uma doença e método de preparação de um medicamento
EE9800119A (et) Mikrokapseldatud putukamürgi preparaadid ja protsess nende valmistamiseks
EE03399B1 (et) Teraapias kasutatavad spiro-asabitsüklilised ühendid ja nende valmistamise protsess
BR9609132A (pt) Composicão e método de tratamento de semente
BR9507999A (pt) Conjugado biologicamente ativo composto substancialmente purificado polimero solúvel em água e composição farmacêutica
PT1003478E (pt) Preparacoes aquosas de aerossol contendo macromoleculas biologicamente activas e processo para a preparacao dos respectivos aerossois
EE9900014A (et) Erütromütsiinid ja nende valmistamise protsess
PT854880E (pt) Novos derivados de 5-o-desosaminil 6-o-metil eritronolido a metodo para a sua preparacao e a sua utilizacao na preparacao de produtos biologicamente activos
MA24800A1 (fr) Agent de blanchiment et son procede de preparation
ATE195069T1 (de) Windel
BR9508320A (pt) Processo para a preparação de um composto e cultura biologicamente
KR950701924A (ko) 신규한 생물학적으로 활성인 에부르나메닌 유도체 및 그 유도체가 함유된 약제학적 조성물과 그 제조방법
EE03440B1 (et) Bioloogilise toimega bensotiasolooni etaanamiinid ja nende valmistamise protsess
EE04371B1 (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
SE9501285L (sv) Förfarande för framställning av biologiskt aktiva proteiner
EE9800164A (et) Farmatseutiline kompositsioon ja meetod epitelioomi raviks
BR9609081A (pt) Combinações de substáncias ativas
BR9610382A (pt) Composição de tratamento do cableo
FR2730242B1 (fr) Composition thermoplastique et procede de preparation
EE03658B1 (et) Pestitsiidpreparaadid ja protsess nende valmistamiseks
FR2743072B1 (fr) Procede de preparation d'acides perfluoroalcanecarboxyliques et perfluoroalcanesulfoniques
FR2741626B1 (fr) Procede de preparation de polysilanes et de polycarbosilanes
ID16176A (id) Penyediaan polipeptida-polipeptida aktif secara biologis

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20011213